Text Size:AAA

Influenza A/Wyoming/03/2003 (H3N2)

Influenza  A/Wyoming/03/2003 (H3N2) Related Products

ProteinAntibodyELISA KitcDNA Clone
ProductMoleculeCat No.Package/Price 
Influenza A H3N2 (A/Wyoming/03/2003) Hemagglutinin / HA Protein (His Tag)HA11715-V08B-50
11715-V08B-100
50 µg/
100 µg/
Add to Cart
Add to Cart
Influenza A H3N2 (A/Wyoming/03/2003) Hemagglutinin / HA Protein (His Tag)HA11715-V08H-50
11715-V08H-100
11715-V08H-10
50 µg/
100 µg/
10 µg/
Add to Cart
Add to Cart
Add to Cart
Influenza A H3N2 (A/Wyoming/03/2003) Hemagglutinin Protein (HA1 Subunit) (His Tag)HA11715-V08H1-50
11715-V08H1-100
11715-V08H1-10
50 µg/
100 µg/
10 µg/
Add to Cart
Add to Cart
Add to Cart

Other InfluenzaH3N2 Strains

Other InfluenzaH3N2 Reagents

Other Products at Sino Biological

Bulk Order, Quotation, Question, E-mail to:order@sinobiological.com

InfluenzaA/Wyoming/03/2003 H3N2Background

Influenza is one of the oldest and most common diseases known to man, causing between three and five million cases of severe illness and between 250,000 and 500,000 deaths every year around the world, and up to millions in some pandemic years. Influenza rapidly spreads in seasonal epidemics affecting 5-15% of the population and the burden on health care costs and lost productivity are extensive (World Health Organization (WHO)). There have been 31 pandemics of which three appeared in the 20th century, namely the 1918 H1N1 (Spanish flu), 1957 H2N2 (Asiatic flu), 1968 H3N2 (HongKong Flu). H3N2 has been the predominant subtype circulating in humans since 1968 and has been in rapid drift as a single lineage while there has been slow replacement of antigenic variants of the H1N1 viruses. Recent years, H3N2 has tended to dominate in prevalence over H1N1, H1N2, and influenza B. Flu vaccines are based on predicting which mutants of H1N1, H3N2, H1N2, and influenza B will proliferate in the next season. Measured resistance to the standard antiviral drugs amantadine and rimantadine in H3N2 has increased from 1% in 1994 to 12% in 2003 to 91% in 2005.

Sino Biological Inc offers Recombinant Hemagglutinin Protein from the A/Wyoming/03/2003 (H3N2) for the research of Influenza.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"